Developer docs
API playgroundTry for free, no card

Search company profiles

BlueYard Capital

Full company profile

uuid00000l5

Namestring
BlueYard Capital
Legal namestring
BlueYard Capital
Websiteurl
blueyard.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

BlueYard Capital is a Berlin-headquartered venture capital firm, founded in 2016 as a small and equal partnership with operational presence in both the United States and Europe. The firm invests $500K to $5M as lead or co-lead in pre-seed through Series A rounds, deploying capital across four explicit theses: Computation & Intelligence, Engineering/Aerospace & Defense, Biology & Chemistry, and Crypto. The firm is currently investing its third fund from a $500M asset base, staffed by 10 investment professionals and 6 operations personnel, with co-founders Ciarán O'Leary and Jason Whitmire serving as general partners.

The firm's product is capital and strategic partnership: BlueYard supplies early-stage funding, follow-on coordination, and a referral-rich founder network to companies building deep, often "radioactive" or misunderstood technologies. The portfolio spans roughly 40+ companies, including contrarian early bets that preceded sector manias — Filecoin/Protocol Labs (2016, crypto), Groq and IonQ (2018, AI compute), and Castelion (2023, defense) — alongside later-stage positions such as Flashbots, Marvel Fusion, Chemify, Privy, and Corintis. Notable exits include IonQ's IPO, Privy's acquisition by Stripe, Peak Games' acquisition by Zynga, FreedomFi's acquisition by Nova Labs, and exits from direct Filecoin holdings.

Economically, BlueYard operates on standard venture-fund mechanics: it earns management fees on committed or invested capital and generates carried interest on profitable exits. Sourcing is predominantly top-of-funnel — driven by founder referrals, the firm's published manifesto and Medium content, and conference presence — with deal evaluation and lead/co-lead participation forming the core distribution channel. There is no disclosed product or technology offering beyond capital allocation and portfolio support, and revenue, LP composition, and individual fund sizes are not publicly disclosed.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital, early-stage investing, deep tech startups, pre-seed funding, infrastructure technology
Industry1 code
1Late-Stage Venture Capital (Series C+)
CodeFSANAAACPrimaryYes
NAICS code1 code
  • All Other Financial Investment Activities52399
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Capital Fund Management
TypeLicensing Royalties
Description

BlueYard Capital manages venture funds and generates returns through equity investments in portfolio companies. They invest in pre-seed to Series A rounds and generate carry/returns when portfolio companies achieve liquidity events through IPOs, acquisitions, or secondary sales.

blueyard.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

BlueYard Capital is a venture capital firm that invests $500K to $5M in pre-seed to Series A rounds as a lead or co-lead investor. The firm deploys capital from its third fund across four focus areas: Computation & Intelligence, Engineering Aerospace & Defense, Biology & Chemistry, and Crypto. It manages $500M in assets under management and targets founders building transformative but often misunderstood or early-stage infrastructure technologies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Multiple successful exits including IonQ IPO, Privy acquisition by Stripe, Peak Games acquisition by Zynga
+1 more record
Product overview1 text field

BlueYard Capital is a venture capital firm that manages $500M in AUM and deploys capital from its third fund. The firm invests $500K – $5M in pre-seed to Series A rounds as a lead or co-lead investor across four focus areas: Computation & Intelligence (applied computation and AI infrastructure), Engineering, Aerospace & Defense (defense technology and aerospace solutions), Biology & Chemistry (biotech and pharmaceutical development), and Crypto (blockchain and decentralized finance). As an investor rather than a product company, BlueYard does not offer a unified platform or product portfolio — its 'offerings' consist of portfolio companies including Corintis (semiconductor cooling), Rapidata (human feedback infrastructure for AI), Cryptio (crypto accounting software), AnySignal (wireless connectivity and space communications), ZeroPhase (communications software for unmanned defense systems), Castelion (hypersonic weapons), and others. BlueYard functions as a financial services firm providing investment capital, not as a technology product provider.

Product and service5 records
1BlueYard Venture Capital Investment Services
CategoryVenture Capital / Investment Services
Description

Venture capital investment services providing $500K to $5M in pre-seed to Series A funding as lead or co-lead investor targeting deep tech founders across four sectors.

2Computation & Intelligence Investments
CategoryVenture Capital - Computation & Intelligence
Description

Investment focus area covering applied computation and AI infrastructure, including portfolio companies such as Corintis, Privy, Groq, SEEQC, and Grid.

3Engineering, Aerospace & Defense Investments
CategoryVenture Capital - Engineering, Aerospace & Defense
Description

Investment focus area covering defense technology and aerospace solutions, including hypersonic missile systems, wireless connectivity for national security, and communications software for unmanned defense platforms.

4Biology & Chemistry Investments
CategoryVenture Capital - Biology & Chemistry
Description

Investment focus area covering biotech, pharmaceutical development, and chemistry automation, including portfolio companies such as Chemify, bit.bio, clock.bio, and Creasallis.

5Crypto Investments
CategoryVenture Capital - Crypto
Description

Investment focus area covering blockchain infrastructure and decentralized finance, including portfolio companies such as Protocol Labs, Flashbots, Miren, and Ingonyama.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Crypto-focused venture firm that has co-invested with BlueYard in Flashbots and Privy. Comparable as a thesis-driven, technically sophisticated investor writing concentrated checks in transformative deep-tech and crypto infrastructure.

TypeDirect peer
Description

Early-stage venture firm that co-invested with BlueYard in Protocol Labs (seed) and Miren (seed). Comparable as a thesis-driven investor focused on foundational internet and crypto infrastructure at pre-seed/seed stages.

TypeDirect peer
Description

Crypto-native venture firm that co-invested with BlueYard in Forta and Radworks. Directly comparable as a small, thesis-driven fund concentrating on decentralized infrastructure and crypto networks.

TypeDirect peer
Description

Crypto-focused venture fund that led Kiln's Series A and co-invested in Cryptio's Series B alongside BlueYard. Comparable as a thesis-driven crypto investor with similar early-stage, infrastructure-heavy orientation.

TypeDirect peer
Description

Crypto-native investment firm that led ETHGas's Series A. Directly comparable to BlueYard's crypto vertical — both write early, concentrated checks in blockchain infrastructure and decentralized protocols.

TypeDirect peer
Description

Deep-tech venture firm investing in frontier science, compute, and defense. Directly comparable to BlueYard's Computation, Aerospace &Defense, and Biology & Chemistry verticals, with similar willingness to back contrarian deep-tech founders.

TypeDirect peer
Description

Thesis-driven venture firm known for contrarian bets on frontier technology (space, biotech, crypto). Comparable to BlueYard in philosophy — investing in 'misunderstood' transformative technologies that mainstream VCs avoid.

TypeBroad incumbent
Description

Multi-stage venture firm that led Castelion's $100M Series A and co-invested in Manex AI with BlueYard. Comparable as a deep-tech investor across defense, AI, and biotech, though much broader and later-stage than BlueYard's focus.

TypeDirect peer
Description

Early-stage venture firm that co-invested with BlueYard in Foresight Data Machines (seed). Comparable as a small, conviction-led fund backing deep-tech and crypto founders at the earliest stages.

TypeDirect peer
Description

Deep-tech and crypto venture firm that co-invested with BlueYard in Ingonyama (seed). Comparable as a thesis-driven fund backing transformative infrastructure in compute, crypto, and frontier science at pre-seed/seed.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment113 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BlueYard Capital

Venture Capitalblueyard.com

What BlueYard Capital does

BlueYard Capital is a Berlin-headquartered venture capital firm, founded in 2016 as a small and equal partnership with operational presence in both the United States and Europe. The firm invests $500K to $5M as lead or co-lead in pre-seed through Series A rounds, deploying capital across four explicit theses: Computation & Intelligence, Engineering/Aerospace & Defense, Biology & Chemistry, and Crypto. The firm is currently investing its third fund from a $500M asset base, staffed by 10 investment professionals and 6 operations personnel, with co-founders Ciarán O'Leary and Jason Whitmire serving as general partners.

The firm's product is capital and strategic partnership: BlueYard supplies early-stage funding, follow-on coordination, and a referral-rich founder network to companies building deep, often "radioactive" or misunderstood technologies. The portfolio spans roughly 40+ companies, including contrarian early bets that preceded sector manias — Filecoin/Protocol Labs (2016, crypto), Groq and IonQ (2018, AI compute), and Castelion (2023, defense) — alongside later-stage positions such as Flashbots, Marvel Fusion, Chemify, Privy, and Corintis. Notable exits include IonQ's IPO, Privy's acquisition by Stripe, Peak Games' acquisition by Zynga, FreedomFi's acquisition by Nova Labs, and exits from direct Filecoin holdings.

Economically, BlueYard operates on standard venture-fund mechanics: it earns management fees on committed or invested capital and generates carried interest on profitable exits. Sourcing is predominantly top-of-funnel — driven by founder referrals, the firm's published manifesto and Medium content, and conference presence — with deal evaluation and lead/co-lead participation forming the core distribution channel. There is no disclosed product or technology offering beyond capital allocation and portfolio support, and revenue, LP composition, and individual fund sizes are not publicly disclosed.

BlueYard Capital firmographics

Firmographics
Name
BlueYard Capital
Legal name
BlueYard Capital
Website
https://blueyard.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

BlueYard Capital industry classification

Industry
Product category
Venture Capital
NAICS
All Other Financial Investment Activities (52399)
SIC
Investment Advice (6282)
akta.pro primary industry
Late-Stage Venture Capital (Series C+) (FSANAAAC)

Keywords

  • Venture capital
  • Early-stage investing
  • Deep tech startups
  • Pre-seed funding
  • Infrastructure technology

Where BlueYard Capital is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

BlueYard Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Venture Capital Fund Management: BlueYard Capital manages venture funds and generates returns through equity investments in portfolio companies. They invest in pre-seed to Series A rounds and generate carry/returns when portfolio companies achieve liquidity events through IPOs, acquisitions, or secondary sales.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

BlueYard Capital product offering

Product offering

Core offering

BlueYard Capital is a venture capital firm that invests $500K to $5M in pre-seed to Series A rounds as a lead or co-lead investor. The firm deploys capital from its third fund across four focus areas: Computation & Intelligence, Engineering Aerospace & Defense, Biology & Chemistry, and Crypto. It manages $500M in assets under management and targets founders building transformative but often misunderstood or early-stage infrastructure technologies.

Product overview

BlueYard Capital is a venture capital firm that manages $500M in AUM and deploys capital from its third fund. The firm invests $500K – $5M in pre-seed to Series A rounds as a lead or co-lead investor across four focus areas: Computation & Intelligence (applied computation and AI infrastructure), Engineering, Aerospace & Defense (defense technology and aerospace solutions), Biology & Chemistry (biotech and pharmaceutical development), and Crypto (blockchain and decentralized finance). As an investor rather than a product company, BlueYard does not offer a unified platform or product portfolio — its 'offerings' consist of portfolio companies including Corintis (semiconductor cooling), Rapidata (human feedback infrastructure for AI), Cryptio (crypto accounting software), AnySignal (wireless connectivity and space communications), ZeroPhase (communications software for unmanned defense systems), Castelion (hypersonic weapons), and others. BlueYard functions as a financial services firm providing investment capital, not as a technology product provider.

Differentiator

Problem solved

Functional benefit

Products and services

  • BlueYard Venture Capital Investment Services Venture capital investment services providing $500K to $5M in pre-seed to Series A funding as lead or co-lead investor targeting deep tech founders across four sectors.
  • Computation & Intelligence Investments Investment focus area covering applied computation and AI infrastructure, including portfolio companies such as Corintis, Privy, Groq, SEEQC, and Grid.
  • Engineering, Aerospace & Defense Investments Investment focus area covering defense technology and aerospace solutions, including hypersonic missile systems, wireless connectivity for national security, and communications software for unmanned defense platforms.
  • Biology & Chemistry Investments Investment focus area covering biotech, pharmaceutical development, and chemistry automation, including portfolio companies such as Chemify, bit.bio, clock.bio, and Creasallis.
  • Crypto Investments Investment focus area covering blockchain infrastructure and decentralized finance, including portfolio companies such as Protocol Labs, Flashbots, Miren, and Ingonyama.

Quantifiable outcome

  • Multiple successful exits including IonQ IPO, Privy acquisition by Stripe, Peak Games acquisition by Zynga
  • +1 more outcomes

Companies that use BlueYard Capital

Customer profile

Segments1 record

Ideal customer profiles1 record

BlueYard Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

BlueYard Capital partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

BlueYard Capital competitors and assessment

Company assessment

Direct peers

  • Paradigm: Crypto-focused venture firm that has co-invested with BlueYard in Flashbots and Privy. Comparable as a thesis-driven, technically sophisticated investor writing concentrated checks in transformative deep-tech and crypto infrastructure.
  • Union Square Ventures (USV): Early-stage venture firm that co-invested with BlueYard in Protocol Labs (seed) and Miren (seed). Comparable as a thesis-driven investor focused on foundational internet and crypto infrastructure at pre-seed/seed stages.
  • Placeholder: Crypto-native venture firm that co-invested with BlueYard in Forta and Radworks. Directly comparable as a small, thesis-driven fund concentrating on decentralized infrastructure and crypto networks.
  • 1kx: Crypto-focused venture fund that led Kiln's Series A and co-invested in Cryptio's Series B alongside BlueYard. Comparable as a thesis-driven crypto investor with similar early-stage, infrastructure-heavy orientation.
  • Polychain Capital: Crypto-native investment firm that led ETHGas's Series A. Directly comparable to BlueYard's crypto vertical — both write early, concentrated checks in blockchain infrastructure and decentralized protocols.
  • Lux Capital: Deep-tech venture firm investing in frontier science, compute, and defense. Directly comparable to BlueYard's Computation, Aerospace &Defense, and Biology & Chemistry verticals, with similar willingness to back contrarian deep-tech founders.
  • Founders Fund: Thesis-driven venture firm known for contrarian bets on frontier technology (space, biotech, crypto). Comparable to BlueYard in philosophy — investing in 'misunderstood' transformative technologies that mainstream VCs avoid.
  • Kindred Ventures: Early-stage venture firm that co-invested with BlueYard in Foresight Data Machines (seed). Comparable as a small, conviction-led fund backing deep-tech and crypto founders at the earliest stages.
  • Walden Catalyst Ventures: Deep-tech and crypto venture firm that co-invested with BlueYard in Ingonyama (seed). Comparable as a thesis-driven fund backing transformative infrastructure in compute, crypto, and frontier science at pre-seed/seed.

Broad incumbents

  • Lightspeed Venture Partners: Multi-stage venture firm that led Castelion's $100M Series A and co-invested in Manex AI with BlueYard. Comparable as a deep-tech investor across defense, AI, and biotech, though much broader and later-stage than BlueYard's focus.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

BlueYard Capital social profiles

Digital presence

BlueYard Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BlueYard Capital leadership team

Management profile

Number of profiles

Profiles17 records

BlueYard Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BlueYard Capital M&A and investment

M&A and investment

M&A

Investments113 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BlueYard Capital

What does BlueYard Capital do?

BlueYard Capital is a venture capital firm that invests $500K to $5M in pre-seed to Series A rounds as a lead or co-lead investor. The firm deploys capital from its third fund across four focus areas: Computation & Intelligence, Engineering Aerospace & Defense, Biology & Chemistry, and Crypto. It manages $500M in assets under management and targets founders building transformative but often misunderstood or early-stage infrastructure technologies.

Is BlueYard Capital a public or private company?

BlueYard Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BlueYard Capital founded?

BlueYard Capital was founded in 2016. It employs 11 to 50 people.

Where is BlueYard Capital based?

BlueYard Capital is headquartered in Berlin, Germany, in the Europe region.

How does BlueYard Capital make money?

One revenue line is on record: venture Capital Fund Management.

Who are BlueYard Capital's main competitors?

Direct peers on record are Paradigm, Union Square Ventures (USV), Placeholder, 1kx, Polychain Capital, Lux Capital, Founders Fund, Kindred Ventures and Walden Catalyst Ventures. Lightspeed Venture Partners is listed as a broad incumbent.

Does BlueYard Capital have an API?

No public API is recorded for BlueYard Capital.

What industry is BlueYard Capital in?

BlueYard Capital's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAC, Late-Stage Venture Capital (Series C+). Its NAICS code is 52399 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsBoxd Raises €2M in Pre-Seed FundingBoxd, an Amsterdam-based cloud virtualization startup, raised €2M in pre-seed funding led by BlueYard Capital. The company will use the capital to accelerate go-to-market, expand engineering, and develop a self-hosted enterprise offering. The platform provides instant, hardware-isolated Linux VMs for developers and AI agents.The SaaS NewsBoxd Raises $2M Pre-seedBoxd, a Dutch startup, raised $2 million in a pre-seed round led by BlueYard Capital. The funding will support scaling its cloud infrastructure platform for AI coding agents and expanding its team. The company plans to further develop its custom virtualization engine.Tech.euBoxd raises $2M to build cloud infrastructure for AI coding agentsBoxd raised $2 million in pre-seed funding led by BlueYard Capital to build cloud infrastructure for developers and AI coding agents. The platform provides virtual machines with snapshotting and live-forking in under 100 milliseconds, aiming to reduce security risks from unsupervised agents. The company will use the funds to expand its team and develop its virtualisation engine.Boxdboxd raises €2M to kill localhostboxd raised €2 million in pre-seed funding led by BlueYard Capital. The company built a cloud platform for remote development with hardware-level isolation and sub-10ms spin-up. It plans to expand beyond development environments as inference becomes cheaper.KuCoinAnonymous Q&A Game Chomp Secures $3.6M in Funding Led by Jsquare and BlueyardChomp, an anonymous Q&A game, raised $3.6 million in funding on August 27, 2026, led by Jsquare and Blueyard. The platform uses prediction and Q&A to uncover user biases and applies anonymized data to AI training. Founder Kiko previously worked at Orca.PhemexChomp Raises $3.6M in Jsquare, Blueyard-Led RoundChomp, an anonymous Q&A social game, raised $3.6 million in a round co-led by Jsquare and Blueyard. The product combines anonymous Q&A with prediction mechanics, and its annotated opinion data can be used for AI model training and consumer research. Founder Kiko previously served as COO of Orca, a Solana-based decentralized trading platform.FinSMEsTranscripta Bio Raises $24M in FundingTranscripta Bio, an AI-powered drug discovery company, raised $24M from Mayo Clinic, Omnimed, JAZZ Venture Partners, BlueYard Capital, and family offices. The funds will expand operations and development efforts, with a pipeline spanning four programs including Myotonic Dystrophy, FSHD, ASD, and Huntington's Disease.LinkedInAfter building Ochre Bio, Jack O'Meara's newest biotech raises $21M for neuro siRNAsAerska, a biotech company developing RNA medicines for central nervous system diseases, has publicly launched with $21 million in seed financing co-led by age1, BACKED VC, and Speedinvest, with participation from BlueYard Capital, Lingotto, Norrsken, Kerna Ventures, PsyMed Ventures, Ada Ventures, and Saras Capital. The funding will support development of the company's 'brain shuttle' technology designed to enable systemic administration of RNA medicines to the brain. The company was founded by Jack O'Meara, who previously built Ochre Bio.LinkedInSemiconductor EngineeringSwiss chip startup Corintis has raised $24 million in Series A funding led by BlueYard Capital to scale its microfluidic chip cooling technology, which Microsoft is already testing and claims is 3x more effective than current systems. The company plans to grow its team from 55 to 70 employees and aims to produce over 1 million microfluidic cold plates annually by 2026. Intel CEO Lip-Bu Tan has joined Corintis' board, signaling strong industry confidence in their thermal management solutions for AI hardware.EIN PresswireCPTx Secures $29 Million to Advance Breakthrough Antiviral PlatformCPTx GmbH secured $29 million in funding led by Blueyard Capital and Germany’s Federal Agency for Disruptive Innovation SPRIND to advance its programmable DNA nanofabrication platform. The company plans to utilize the capital to accelerate the development of its antiviral pipeline, which includes a pan-influenza candidate, and expand its operational team. This investment supports the commercialization efforts of a technology derived from 15 years of research at the Technical University of Munich.